Advertisement
Table 3 Prevalence of the various metabolic syndrome risk factors among the study population classified by sexual function
| Variable | Total (n = 274) | NSD (n = 84) | SD (n = 190) | P value |
|---|---|---|---|---|
| WHO | ||||
| Central Obesity – WHR | 210(76.6%) | 58(69.0%) | 152(80.0%) | 0.0482 |
| Raised fasting glucose | 274(100.0%) | 84(100.0%) | 190(100.0%) | |
| Hyperlipidaemia | 131(47.8%) | 36(42.9%) | 95(50.0%) | 0.2751 |
| Raised blood pressure | 163(59.5%) | 47(56.0%) | 116(61.1%) | 0.4278 |
| NCEP ATP III | ||||
| Abdominal Obesity – WC | 53(19.3%) | 13(15.5%) | 40(21.1%) | 0.2813 |
| Raised fasting glucose | 274(100.0%) | 84(100.0%) | 190(100.0%) | |
| Raised Triglyceride | 88(32.1%) | 25(29.8%) | 63(33.2%) | 0.5788 |
| Raised blood pressure | 200(73.0%) | 54(64.3%) | 146(76.8%) | 0.0309 |
| Reduced HDL-C | 78(28.5%) | 21(25.0%) | 57(30.0%) | 0.3978 |
| IDF | ||||
| Abdominal Obesity – WC | 178(65.0%) | 52(61.9%) | 126(66.3%) | 0.4804 |
| Raised fasting glucose | 274(100.0%) | 84(100.0%) | 190(100.0%) | |
| Raised Triglyceride | 88(32.1%) | 25(29.8%) | 63(33.2%) | 0.5788 |
| Raised blood pressure | 200(73.0%) | 54(64.3%) | 146(76.8%) | 0.0309 |
| Reduced HDL-C | 78(28.5%) | 21(25.0%) | 57(30.0%) | 0.3978 |
